Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | DF6002 |
| Trade Name | |
| Synonyms | DF-6002|DF 6002 |
| Drug Descriptions |
DF6002 is a fusion protein consisting of interleukin-12 (IL-12) linked to an Fc fragment, which binds to the IL-12 receptor and may lead to activation of the immune response, inhibition of tumor cell proliferation and tumor cell killing (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C173371 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| DF6002 | DF6002 | 0 | 1 |
| DF6002 + Nivolumab | DF6002 Nivolumab | 0 | 1 |
| DF6002 + Pembrolizumab | DF6002 Pembrolizumab | 0 | 0 |